Company discovery

Vertical AI agents for regulated industries (healthcare, legal, finance), pre-Series A

August 26, 2026 · $0.11 for both answers and the judge

DeepSeek V4 Pro wins

On August 26, 2026, Claude Fable 5 and DeepSeek V4 Pro each wrote a company shortlist for the same brief, without seeing the other's answer. The judge, Gemini 3.1 Pro, read both twice, once in each order, and picked DeepSeek V4 Pro both times.

Why, in the judge's words“Response B provides specific funding amounts to justify the pre-Series A constraint, whereas A includes several companies it admits are likely past Series A.”

The two answers

Claude Fable 5
$0.061 · 21s · 1,184 tokens

Here are 10 real companies fitting the brief. Note: stage data moves fast — I've flagged where funding status should be re-verified.

Healthcare

  1. Tennr — AI agents that read faxes/referrals and automate patient intake workflows for specialty clinics. Fits earlier vintage of thesis; raised seed from a16z before scaling — worth studying as a pattern-match even though now past Series A. (Include as comp, not target.)
  2. Anterior (fka Co:Helm) — AI clinical reasoning agents for prior authorization on the payer side. NEA-backed, small team, founder is a physician; early enterprise pilots with health plans. Verify current round.
  3. Hona Health (fka Medplace adjacent space) — if unverifiable, substitute: Cofactor AI — AI agents that draft appeals for denied hospital claims. Pre-seed/seed, launched out of stealth 2024, clear wedge into revenue cycle.
  4. Tandem Health — AI clinical copilot/scribe agents for European healthcare systems (Sweden). Seed stage, strong regulatory (GDPR/MDR) moat angle.

Legal

  1. Marveri — AI agents for legal due diligence document review for M&A lawyers. MIT-founded, seed stage, early law firm pilots.
  2. Solve Intelligence — AI agents for patent drafting and prosecution. YC-backed, seed stage, revenue with IP law firms.
  3. DraftWise — AI drafting/negotiation agent built on firms' own precedent databases. Ex-Palantir founders; raised seed/Series A boundary — verify.

Finance

  1. Greenlite — AI agents for AML/KYC compliance operations at fintechs and banks. YC-backed, seed stage, strong logo traction (fintech compliance teams).
  2. Norm Ai — regulatory compliance converted into executable AI agents for financial institutions. Raised early rounds quickly from Coatue; verify stage — may have passed Series A.
  3. Hadrius — AI compliance agents for SEC-regulated investment advisors (marketing review, trade surveillance). YC-backed, seed, fast-growing RIA customer base.

Two white-space gaps:

  1. Agentic audit & assurance. Almost no one is building AI agents for the auditor side (financial audit workpapers, SOC 2 evidence testing, clinical trial monitoring/GCP audits). Everyone builds for the regulated entity; the verification layer is underserved and has forced, recurring demand.
  2. Cross-border regulatory arbitrage agents. Companies operating across jurisdictions (EU AI Act + FDA + MDR; or multi-state insurance/pharmacy licensing) have no agent that tracks divergent rules and drives filings. Multi-state licensing ops alone (telehealth, insurance producers, money transmitters) is painful, fragmented, and mostly manual today.

Caveat: I have not invented any names, but seed/Series A status shifts quickly — items 1, 7, and 9 in particular may have graduated past your stage filter and should be confirmed against PitchBook/Crunchbase before outreach. Item 3's first-listed name I'm unsure of, so treat Cofactor AI as the pick.

DeepSeek V4 ProWinner
$0.030 · 178s · 7,536 tokens

Based on last disclosed rounds; all are seed/pre-seed rather than priced Series A.

  1. Greenlite — AI compliance agents for fintechs and banks that automate KYC/KYB, sanctions/watchlist screening, and SAR drafting.
  2. Why it fits: Seed-stage (~$4.8M, YC-backed); sells directly into regulated financial compliance teams.
  3. Tennr — AI agent for healthcare providers that reads faxed referrals and medical records, then automates patient intake, insurance verification, and scheduling.
  4. Why it fits: Seed-stage; targets a heavily regulated healthcare operations workflow with acute labor pain.
  5. Anterior — AI agent for health plans that automates prior authorization by reviewing clinical records against payer medical policy.
  6. Why it fits: Seed-stage (~$7M); pre-Series A, focused on a regulated payer/provider bottleneck.
  7. Freed — Ambient AI scribe and clinician back-office agent that writes clinical notes, referral letters, and handles charting busywork.
  8. Why it fits: Seed-stage (~$11.5M); early traction with clinicians while staying pre-Series A.
  9. Tandem Health — AI scribe and administrative agent for primary care that generates clinical notes, care plans, and follow-up actions.
  10. Why it fits: Seed-stage (~$9.5M); less-known than larger scribe incumbents and still pre-Series A.
  11. Paxton AI — Legal AI agent for regulatory tracking, legal research, and contract review used by law firms and compliance teams.
  12. Why it fits: Seed-stage (~$6M); pre-Series A, direct fit for legal/regulatory workflows.
  13. CaseMark — Legal AI workflow assistant that summarizes depositions, medical records, and drafts litigation-related documents.
  14. Why it fits: Pre-seed/seed (~$1.7M); very early, under-the-radar legal AI agent.
  15. Ivo — AI contract review agent for in-house legal teams that redlines and negotiates agreements against internal playbooks.
  16. Why it fits: Seed-stage; focused legal agent with clear enterprise ROI and pre-Series A profile.
  17. Effectiv — Fraud and compliance AI agents for banks and fintechs, automating transaction monitoring, KYC reviews, and case management.
  18. Why it fits: Seed-stage (~$4.5M); sells into regulated financial institutions with agentic compliance workflows.
  19. Fairly AI — AI governance, risk, and compliance agents for financial services; automates regulatory change management, control testing, and model risk documentation.
  20. Why it fits: Seed-stage; targets regulated financial compliance rather than generic AI governance.

White-space gaps noticed while sourcing:

  • Healthcare audit/revenue integrity agents: Most early healthcare agents are scribes or prior-auth tools. There is room for an agent that combines clinical documentation, coding, payer policy, and denial risk to produce audit-ready charts and defend medical necessity.
  • SEC/securities filing agents for small public companies: Legal AI is crowded in generic contract review, but automated 10-K/10-Q/8-K drafting, XBRL tagging, and SEC comment letter response for small caps remains under-served and deeply regulatory.

Claude Fable 5 vs DeepSeek V4 Pro, overall

Across 27 judged battles, Claude Fable 5 won 22, DeepSeek V4 Pro won 3, and 2 were ties. On company discovery alone: 6 to 1.

Costs are the provider's list prices at the time of the run.